BELANOFF JOSEPH K (Chief Executive Officer) sold 0.9% of their position (26.20K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $1.31M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/27/2026ACC: 0001193125-26-129143
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-26.20K
Net shares
Net seller
$1.31M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
26.20K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−26.20K
Price / share
$50.07
Trade value
$1.31M
% of position
0.9%
3/25/2026
2.94M→2.92M
Total
Net shares
−26.20K
Net value
-$1.31M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/25/2026 | S · Sale | −26.20K | $50.07 | $1.31M | 0.9% | 2.94M | 2.92M |
| Total | −26.20K | -$1.31M | ||||||
Derivative Transactions0
No derivative transactions reported